GLP-1RAs for the treatment of obesity in women after menopause

Maturitas. 2022 Feb;156:65-66. doi: 10.1016/j.maturitas.2021.12.003. Epub 2021 Dec 11.
No abstract available

Keywords: Diabetes; GLP-1RA; Incretins; Menopause; Obesity.

Publication types

  • Editorial

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Female
  • Humans
  • Hypoglycemic Agents*
  • Menopause
  • Obesity
  • Treatment Outcome

Substances

  • Hypoglycemic Agents